戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 518作成日:2026年10月25日

1,4-Dibromobenzene → Ethyl 1-(4-bromophenyl)piperidine-4-carboxylate

https://huagongshe.com/reaction/518

反応式

関与物質

役割名称HCID仕込み量
反応物1,4-DibromobenzeneHCID 7804—
反応物Ethyl 4-piperidinecarboxylateHCID 70770—
試薬Sodium t-butoxideHCID 23676156—
触媒Binap, (A+-)-HCID 634876—
触媒Bis(dibenzylideneacetone)palladiumHCID 9811564—
溶媒TolueneHCID 1140—
生成物Ethyl 1-(4-bromophenyl)piperidine-4-carboxylateHCID 7109366759.1%

反応条件

温度85 °C

反応手順

A suspension of ethyl piperidine-4-carboxylate (3.27 mL, 21.20 mmol), 1,4-dibromobenzene (5 g, 21.20 mmol), TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (0.485 g, 0.53 mmol), 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (0.990 g, 1.59 mmol) and Sodium Tert-Butoxide (2.444 g, 25.43 mmol) in anhydrous toluene (60 mL) was stirred at 85 °C under nitrogen for 16 hours. The reaction was cooled to ambient temperature, diluted with Ether (100 mL) and filtered through celite. The filtrate was evaporated in vacuo to yield crude product. The crude product was purified by flash silica chromatography, elution gradient 0 to 20% EtOAc in heptane. Pure fractions were evaporated to dryness to afford ethyl 1-(4-bromophenyl)piperidine-4-carboxylate (3.91 g, 59.1 %) as a yellow oil.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-6d4c20d55c834a949848dd34c3fa431d
出典メモ750 AstraZeneca ELN dataset